Analysts/Institutional Investor Meet/Con. Call Updates

Date: November 03, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (E), Mumbai – 400051 BSE Scrip Code: 545005 NSE Scrip Symbol: PARASHLTH Subject: Schedule of Earnings Conference Call under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/Madam, Pursuant to Regulation 30 read with Para A of Part A of Schedule III to the SEBI Listing Regulations, as amended, we wish to inform you that the Company has scheduled an Earnings Conference Call with investors/analysts on Friday, November 06, 2026, at 05:30 p.m. (IST), as per the details enclosed herewith, to discuss its Financial Results for the quarter and half year ended September 30, 2026. Please note that no unpublished price sensitive information is proposed to be shared by the Company during the aforesaid Earnings Conference Call. This disclosure will also be hosted on the Company’s website at https://www.parashospitals.com/investors. We request you to kindly take the same on your record. Thanking you. For Paras Healthcare Limited Rahul Kumar Company Secretary and Compliance Officer ICSI Membership No.: A20928 JM Financial Institutional Securities Limited invites you to Q2 and H1FY27 earnings conference call with Paras Healthcare Limited Friday, 6th November 2026 05:30 PM IST | 07:00 AM USA | 12:00 AM UK | 08:00 PM HK/SINGAPORE Company Participants Dr. Dharminder Kumar Nagar Managing Director Mr. Dilip Bidani Group Chief Financial Officer Universal Dial-in: +91 22 6280 1366 | +91 22 7115 8267 Toll-free Number – International USA: UK: Singapore: Hong Kong: 1 866 746 2133 0 808 101 1573 800 101 2045 800 964 448 Please dial in 10 minutes prior to the conference schedule to ensure that you are connected in time Diamond Pass Link For further information, please contact: Mr Amey Chalke | +91 9664976620 | amey.chalke@jmfl.com Mr Abin Benny | +91 7710066464 | abin.benny@jmfl.com Mr Gourav Bhama | +91 9650984629 | gourav.bhama@jmfl.com JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED Corporate Identity Number: U67100MH2017PLC296081 Member of BSE Ltd. and National Stock Exchange of India Ltd. SEBI Registration Nos.: Stock Broker - INZ000163434, Research Analyst - INH000000610 Registered Office: 7th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai 400 025, India. Board: +9122 6630 3030 | Fax: +91 22 6630 3488 | Email: jmfinancial.research@jmfl.com | www.jmfl.com Compliance/Grievance Officer: Ms. Ashley Johnson | Tel: +91 22 6224 1862 | Email: instcompliance@jmfl.com Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Safe harbour The proposed management discussion and comments thereof may include forward-looking statements. Forward-looking statements are statements that concern plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical fact. All forward looking statements are subject to risks, uncertainties and assumptions that could cause actual results of operations and financial conditions to differ materially from those contemplated by the relevant statement. All Conference Call Participants should not place undue reliance on these forward-looking statements. Registration granted by SEBI and certification from the National Institute of Securities Market (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors.